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32. Standardization of Results Obtained
with Difierent Thromboplastin Ptepatations
E. A. LorlIcnn, \7. K. TecoNIS' J. J. Vei,rr<nMn, and H. C. Hsln{rsn
It is beyond doubt that the ratio method conceived and worked out by Biggs
and Denson (1) is invaluable for daily practice and even more so for clinical
researd-r. At the !967 meetjng of the Subcommittee of Thromboplastin Standards
in 
'$flashington, however, it was cLear that four relevant problems were still un-
solved (8, 1O). These problems concern: 1. The theoretical basis of the ratio method;
2. the statistical validity of the ratio method; 3. the definition of an absolute stand-
ard;4. the proposal of a standard reference preparation. Since 7967,we have in-
creased our experience and feel able to clarify some of these problems.
Theoretical basis
Biggs and Denson have put forward strong arguments in favor of the hypothesis
that the correlation between the ratios found with two different thromboplastin
preparations in plasmas from patients treated with coumarin congeners is recti-
linear and that the line goes through the point defined by ratio 1 of the fwo axes
of the diagram. Rectilinearity is assumed to be the result of rectilinearity of the
underlying correlations of coagulation time ratios with the inverse of the concen-
tration of coagulation factors present in the coumarin plasma, a correlation known
from normal plasma containing different amounts of coagulation factors (2, 4).
The hypothetical intersection at the point (x : 1, y : 1) defined in the ratio plot
is based on the assumption that the correlation curves obtained from the two
thromboplastin preparations display the same behavior as do, by definition, the
lines obtained from normal plasma.
Concerning the first assumption, we now have enough evidence to be certain
that in plasma from coumarin-treated patients (under the condition of stable hypo-
coagulability) the correlation between the coagulation time ratios and the inverse
of the concentration of the coagulation factors involved is indeed recdlinear, pro-
vided the thromboplastin preparation used is free of important factor VII-like
Haematology Section of the Department of Internal. Medicine, Universiry Flospital, Leiden,
The Netherlands.
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acriyiry. The most convincing cdrves are obtained with Thrombotest (Fig. 1) and
with Simplastin (Fig. 2).
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Fig.2. Results obtained with Simplastin in samples of the same 15 plasmas'
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Re-examination of the curve obtained with Thrombotest (Fig. 3) shows not only
rectilinearity but also that the correlation line is mudr steeper than the correspond-
ing line obtained from normal plasma. (Coagulation time ratios obtained when
testing normal plasma in different dilutions with buffer, e.g., a rlrc dilution corre-
sponds to 1,0 Vo factor X.) The line does not pass through point (x: 1., y: 1) ds-
fined in the ratio plot as does, by definition, the line obtained from normal plasma.
In the patient, point 1 of the x-axis (: 100 % factor X) corresponds to a
virtual ratio (or y-value) of t.l7 . This point is found by rectilinear extrapolation
of the correlation line found for therapeutic values. (Virtual ratio means the ratio
expected in a patient which under the condition of stable coumarin treatment dis-
plays 100 % factor X activity whicl, in practice, is not expected to occur.)
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Fig. 3. The correlation lines found with Thrombotest for coumarin plasma and normal plasma.
Both intersect the y-axis at the same poinl..Af 1000/o factor X activity, the (virtual) ratio for
patients is 1.17.
This upward deviation of the line found in p"ti.nt, as compared to the correla-
tion line obtained from normal plasma is not at all astonishing, if we consider that
coumarin congeners not only induce a depression of the four factors of the pro-
thrombin complex, but also provoke the appearance in the circulation of a protein,
called PIVKA, that acts as a competitive inhibitor of the thromboplastin time re-
action and whose concentration is independent of the level of hypocoagulability(s ).
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Differences in PIVKA sensitivity of the different thromboplastin preparations
may cause more or less obvious deviations from the ratio correlation line proposed
by Biggs and Denson. The deviations found, however, are minimal: for instance,
if the ratios found with Thrombotest, whicl is highly sensitive to both a coagula-
tion factor deficiency and PIVKA, are correlated with the ratios obtained for
Simplastin, which displays a relatively low sensitivity to the coagulation factor
deficiency, then, in spite of the very low PIVKA sensitivity of Simplastin, the
deviation is minimal (Fig. a).
3
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Fig.4. The correlation line obtained from the ratios found qith Thrombotest and Simplastin. Tl
deviation is, as can be assessed from the higher magnification, approx. 0.07 on the y-axis and 0.01
on the x-axis.
Another cause of deviation from the corelation line proposed by Biggs a
Denson is the non-rectilinearitv of the correlation line obtained with thrombo
plastins possessing important factor VII-like activity. 'I7ith such thromboplasti
the correlation lines may be distinctly curved and show flattening toward the rig
the part of the curve falling in the therapeutic range of coumarin-induced
coagulability being rectilinear, however. The line found for Geigy thromboplasti
is an example of this kind of behavior, suggesting a curved shape of the li
between [100] and [40] and showing rectilinearity in the therapeutic ra
Fig.5). ' t
* The curved shape is well known from the standard reference curve.
.o
E,
n
o
o
ll
E
o
4
F
Standardization of Di-ff erent Thromboplastin Preparations 373
-13 s6t=
E l d
o l t r
ol s-
- l ?  2
t -
,-rqo so zo ro i8:l3ilJ.;/re,
o  1 2  5  l o . l q g -
{"l,)
Fig' 5. The curved correlation line obtained with Geigy thromboplastin. The steep dotted lines
would be obtained if Geig'y thromboplastin were free of factor Vfi-like acuvity. fhe flat doaed
line is an extrapolation of the rectilinear correlation line found in rhe therapeuric range: ir goes
o
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Fig.6.correlation line obtained rro," r'r,j'tTiIt'lr,lltl.,*, thromboplastin and simplastin.
The line is rectilinear, but obviously does not pass through point (r, 1); afx : 1, y is abo"t r.zo.
Although, in the therapeutic range, the steepness of the line found for Geigy
thromboplastin is very similar to that found for Simplastin, the ratios are clearly
different; the virtual y-values ar [1oo] factor X (obtained by extrapolating the
lines found for the therapeutic range) for Geigy thromboplastin and Simplastin
are 1.22 and 1.025, respectively. This difierence causes deviations from the be-
havior postulated by Biggs and Denson, and these deviations are clearly larger
than those caused by PIVKA (Fig. 6).
through ay-va.lue of 1,22 ll00l factor X concentration.
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On the other hand, as may be concluded from both Fig. 4 and Fig. 6 (the latter
showing the maximum deviation found), the influence of PIVKA and of the factor
VII-like activity of certain thromboplastins by no means detracts from the prac-
tical value of the ratio method proposed by Biggs and Denson.
These results represent our contribution to the theoretical basis of the ratio
method and its practical implications.
Statistical validity of the tatio method
The second problem - that of the statistical validity of the ratio method - is
closely related to the first one. Our results strongly suggest that in the therapeutic
range there is a rectilinear correlation between ratios and the inverse of factor X
concentration for all thromboplastins. This is strong evidence in favor of a recti-
linear correlation between the various ratios, too. Deviations from the hypotheti-
cal intersection at point (x:l,y:1) through the influence of PIVKA of factor
VII-like actiyity of thromboplastin may explain the criticism put forward by Lit-
tell and Ratnoff at the 19 66 and 1967 meeting (6, 7). ln the majority of cases, how-
ever, this deviation is too small to be expressed in the correlation line constructed
through the points found from 20 individual samples. This means that the ratio
method proposed by Biggs and Denson is to be considered valid for all practical
purposes, a conclusion forwarded by Murphy at the \Tashington meeting in 1'967
(3).
Deviations of the results obtained with individual plasmas from the best-fitting
rectilinear correlation curve, however, are often larger than would be expected from
the technical error alone. The explanation for this may be in one of the following
three possibilities: a. differences in the sensitiviry of thromboplastins for factors VII
and X and for PIVKA; in individual plasmas the levels of these factors show rather
large mutual differences, even under stable anticoagulant reatment; b. differences
in the sensitivity to factor V and other (coagulation) factors in prothrombin time
estimations; c. differences in the amounts of plasma present in the test system (the
result of whole-blood procedures depend on the hematocrit).
Deviations are especially large when results obtained with human brain and
animal mateial are compared. Although the underlying cause is not yet fully
understood, it may be an exceptional factor VII sensitivity of human brain
thromboplastin.
To elimi,nate the influence of these rather large deviations as mudr as possible,l
the number of samples tested should be higher than 20, which means that the help
of a specialized reference laboratory would often be necessary.
Standardization of Different Thromboplastin preparations
Definition of an absolute standard
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Concerning the third problem, the definition of an absolute standard, the follow-
ing may be stated: at.present, thromboplastins are tested on normal plasma and
plasma dilutions. Under special conditions, standard reference curves can be ob-
tained that reflect the sensitivity of a thromboplastin with respecr to factors II,
VII, and X. But even under optimal conditions of standardi)ation, sensitivity,
and hence ratios' differ from batdr to batcl. Moreover, standa rdization ug i*i
normal plasma tells us nothing about possible differences in PIVKA sensitivitv
between different batches. And this sensitivity, too, is all-important for the r"rult,(c.q. ratios) obtained from coumarin plasmas.
, 
At present, the only sensible way to define an absolute standard with respect o
the coumarin-induced coagulation defect as a whole is to preparelargepools of
coumarin plasma containing known amounts of coagulation factors. \[e are fully
aware of the fact that sudr standardization needs exceptional facilities. \7e think,
however, that our Thrombosis service would be able io satisfy many of the pre-
requisites for absolute standardization.
Proposal for a standardized reference preparation
As to the fourth and last problem, that of shndard preparations, which has been
extensively discussed by Biggs (9), we have nothing to add.
Conclusion
The ratio method of Biggs and Denson is valid, in spite of the fact that the theo-
retical basis of this method is not entirely in accordance with the original assump-
tions.
Absolute standardization is feasible, although it will be difficult to realize.
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